Clinical Trial Update: Staccato Loxapine Pulmonary Safety in Patients With Asthma [Phase 1]

View source ↗

Summary

A Phase 1 trial assessed the pulmonary safety of Staccato Loxapine in adults with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Staccato Loxapine (loxapine)

Snippet

Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Asthma | Phase 1 | Status: COMPLETED